Srilaxmi Kalavalapalli,
Medical Scientist IV; Manager, Endocrinology & Diabetes Research Laboratory
Department:
MD-ENDOCRINOLOGY
Business Phone:
(352) 273-8490
Business Email:
srilaxmi.kalavalapalli@medicine.ufl.edu
On This Page
Publications
Academic Articles
Grants
-
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus
Active
- Role:
- Other
- Funding:
- BOEHRINGER INGELHEIM PHARM INC
Contact Details
Phones:
- Business:
- (352) 273-8490
Emails:
- Business:
- srilaxmi.kalavalapalli@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100226
GAINESVILLE FL 32610 - Business Street:
-
1600 SW ARCHER RD
GAINESVILLE FL 32610